Oscar Health Inc (OSCR) PT Raised to $49 at Barclays

September 17, 2026 4:35 AM

Barclays analyst Andrew Mok raised the price target on Oscar Health Inc (NYSE: OSCR) to $49.00 (from $39.00) while maintaining a Overweight rating.

No results found